Host: Matt Birnholz, MD

Guest: Rishi P. Singh, MD

The past 40 years have witnessed great advancements in therapeutic options for treating diabetic retinopathy. Despite a number of effective treatment options, diabetic eye disease is one of the leading causes of vision loss in the United States, in part because many patients are not identified as needing therapy. In addition to counseling patients on the importance glucose control on maintaining vision, clinicians should emphasize the need for regular vision tests among patients with diabetes. Early detection offers the best long-term visual outcomes and is even more important with new treatments approved for the management of diabetic retinopathy. As a value added-resource, a specialized toolkit will also be included as a supplement to the webcast. The toolkit will provide for clinicians clinical practice guidelines and recommendations for screening and diagnosis. In addition, the toolkit will provide helpful information and resources for patients, their families and caregivers.